CTIC

CTI BioPharma Corp. (DE) Common Stock

Delisted

CTIC was delisted on the 23rd of June, 2023.

55 hedge funds and large institutions have $126M invested in CTI BioPharma Corp. (DE) Common Stock in 2021 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 22 increasing their positions, 11 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
55
Holders Change
-7
Holders Change %
-11.29%
% of All Funds
0.97%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
7
Increased
22
Reduced
11
Closed
13
Calls
$443K
Puts
$580K
Net Calls
-$137K
Net Calls Change
-$690K
Name Holding Trade Value Shares
Change
Shares
Change %
EI
51
EAM Investors
California
-$773K -240,108 Closed
6CM
52
683 Capital Management
New York
-$355K -110,251 Closed
Goldman Sachs
53
Goldman Sachs
New York
-$185K -57,586 Closed
BFM
54
Boothbay Fund Management
New York
-$126K -39,106 Closed
JF
55
Jump Financial
Illinois
-$125K -38,800 Closed
AGM
56
Alpine Global Management
New York
-$105K -32,720 Closed
Capstone Investment Advisors
57
Capstone Investment Advisors
New York
-$89K -27,770 Closed
MFS
58
Mirabella Financial Services
United Kingdom
-$89K -27,550 Closed
SFI
59
Susquehanna Fundamental Investments
Pennsylvania
-$82K -25,597 Closed
TRCT
60
Tower Research Capital (TRC)
New York
-$77K -23,865 Closed
VF
61
Virtu Financial
New York
-$59K -18,385 Closed